Table of Contents [click to go to item]:
Welcome
The Virtual Retinal Display
How the VRD Works
Who Can Benefit from the VRD
Future Developments with the VRD
Commercial Development
Contacting Us


Welcome

Thank you for inquiring about the potential application of the Virtual Retinal Display as an assistive device for people with low vision. Many people with low vision, their family members, and friends are looking for assistive devices and techniques to enable improved performance of daily visual tasks at home, at work, and in the community. We believe that the technology of our Virtual Retinal Display can provide an important new tool for people with low vision. At this point the technology is in prototype stages. With further refinements and miniaturization we are working toward making this technology available as personal use products by people with low vision. We are working with our corporate partner to make products commercially available to the public soon.
 

The Virtual Retinal Display

The VRD, as we call it, is a completely new way of creating images upon the retina of the human eye. The VRD was invented and patented here at the Human Interface Technology Laboratory (HIT Lab) on the campus of the University of Washington by Dr. Thomas A. Furness III, the director of the laboratory. Dr. Furness was recently honored as the recipient of the 1998 DISCOVER Magazine Award for Technological Innovation in the SIGHT category. Perhaps your interest in the VRD came from publicity resulting from this award. Instead of using the eye to focus on a video screen or a computer screen, our new VRD scanner technologies converts these electronic messages and "paints" images such as pictures and print directly onto the retina. We believe that the VRD will be a useful low vision aid for people who have a broad variety of eye conditions that cannot be improved via standard eye care procedures or by many currently available low vision aids.
 

How the VRD Works

The VRD uses a very narrow beam of scanned light to enter the eye. If the optics of one's eye are impaired or otherwise create distortions, we can pass VRD laser beams through many of these problem areas and onto the retina. To illustrate, eyeglass wearers with low vision who have tried the VRD report seeing the exact same quality of image both without their eyeglasses and when viewing through any portion of the lenses of their glasses, including any bifocal or trifocal lenses. Once the narrow VRD beam has passed through one's glasses and the iris of one's eye, the scanning feature of the VRD causes the beam to widen on its path to the retina. When the image reaches the retina it is about 30 degrees wide. While this is more than sufficiently wide for reading, we are working ways to increase this width for some applications. If the retina of one's eye is impaired, we can use the VRD to provide an image that is much sharper and can be controlled to be much brighter than other displays. Since the VRD does depend upon the reception of an image by the retina and a functioning optical nerve pathway in the brain, the VRD will not work for people who have complete loss of retinal or optic nerve functions.
 

Who Can Benefit from the VRD

According to the Washington State Department of Services for the Blind, about 93,000 people in Washington State and 4.4 million people the United States currently have useable vision that is amenable to improved visual functioning via appropriate low vision aids and techniques. By the year 2020, this number will swell to about 159,000 in Washington State and 7.6 million people in the United States. We are confident that the VRD has the potential of being a significant low vision aid for a wide range and large number of these people.
 

Future Developments with the VRD

The present status of our research in the application of the VRD for low vision is exciting, but preliminary. Our current laboratory versions of the VRD are bulky and must be operated by our engineers. We have tested the VRD with a large number of people with a variety of visual disorders. We have promising data that shows the VRD can be a significant low vision aid for many people, yet we need to learn more about the applicability for several other kinds and degrees of low vision. Our primary job right now is to secure additional funding from business or government agencies to help us do more tests and design improved VRD devices with perhaps individualized applications for people with of low vision. We have been very fortunate and have some funding from the National Science Foundation, a Federal government research agency, to help us in our initial development work.
 

Commercial Development

A corporate partner of the Human Interface Technology Laboratory is a Seattle firm called Microvision. Microvision is hard at work developing VRD products for medical and military applications as well as high quality, inexpensive, and compact versions of the VRD. We hope these versions will be adapted for use by people with low vision and made available as products to the public soon. We are working with Microvision toward this end.
 

Contacting Us

We know that people with low vision are anxious to use technological breakthrough devices and we are doing our best to assure that future versions of the VRD will be available for users soon. We ask for your patience as we carry out our research with low vision subjects from state and local agencies.  Information about future VRD studies for low vision persons in the Seattle metro area will be accessible on this web site.  We are sorry that we cannot begin to fulfill the many requests we have by individuals with low vision to try the VRD.  Our progress will be posted on our web site that can be accessed on the Internet at www.hitl.washington.edu. If you have ideas for helping our research efforts, either with funding or technology, please email us at the links below or send us a letter at :


Human Interface Technology Laboratory
University of Washington
Box 352142
Seattle, WA 98195-2142


Eric J. Seibel, Ph.D., Research Assistant Professor
Suzanne Weghorst, M.S., Senior Research Scientist
Ron Merryman, M.S., Research Associate


 
  (Updated on September 5, 2001 by Dr. Eric Seibel.  Prepared on November 20, 1998 by Dr. Erik Viirre, M.D., Ph.D.)